This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Intraoperative floppy iris syndrome (IFIS)

Authoring team

Intraoperative floppy iris syndrome (IFIS) was first described by Chang and Campbell in 2005

  • defined by flaccid iris stroma resulting in fluttering and billowing of the iris, tendency of iris prolapse through the surgical incisions and progressive intraoperative pupil constriction
    • IFIS can be characterized as complete, when all the three features are present or incomplete, when even one feature is missing
    • IFIS may lead to complications, such as posterior capsular rupture, loss of vitreous, iris prolapse, iris stroma atrophy, capsulorhexis tear, and anterior chamber hemorrhage, due to restricted surgical field secondary to miosis

  • there is a reported association between IFIS and taking alpha blockers, which are commonly used for the treatment of benign prostatic hyperplasia
    • IFIS has been associated with use of tamsulosin, doxazosin, terazosin; also with labetalol (a selective alpha and beta blocker)
    • study evidence suggests risk of IFIS is highest with use of tamsulosin of all the alpha blockers
    • there are case reports of other associations with development of IFIS including use of antipsychotics, losartan and metformin
  • systemic factors that have been implicated for IFIS predisposition include diabetes and hypertension

Consider intracameral phenylephrine to increase pupil size in people at risk of floppy iris syndrome (4).

Reference:

  • Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 2005; 31: 664-673.
  • Altiaylik Ozer P, Altiparmak UE, Unlu N, Hazirolan DO, Kasim R, Duman S. Intraoperative floppy-iris syndrome: comparison of tamsulosin and drugs other than alpha antagonists. Curr Eye Res 2013; 38: 480-486.
  • Schwinn DA, Afshari NA. alpha (1)-adrenergic receptor antagonists and the iris: New mechanistic insights into floppy iris syndrome. Surv Ophthalmol. 2006;51:501-12.
  • NICE (October 2017). Cataracts in adults: managementacts in adults: management

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.